CLIA lab

CLIA 44D0856674: Access Clinical Trials, Inc

Nashville, TN. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 44D0856674 belongs to Access Clinical Trials, Inc in Nashville, TN.

Certificate of Waiver, effective September 1, 2026, expires August 31, 2028.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
September 1, 2026
Certificate expiration
August 31, 2028
Status in the CMS file
Active (termination code 00)
Original participation date
January 4, 1993
Facility type
Other
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory
Directly affiliated labs
1

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
44D0856674
Lab name
Access Clinical Trials, Inc
Address
2201 Murphy Ave, Suite 212, Nashville, TN 37203
Phone
(615) 320-6076
Fax
(615) 320-6068

Annual test volume the lab reported

Waived tests
30

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Nashville, TN

Related

Questions

What is the CLIA number for Access Clinical Trials, Inc in Nashville?

44D0856674, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Access Clinical Trials, Inc hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 44D0856674 expire?

The CMS file lists August 31, 2028 as the certificate expiration date; the certificate took effect September 1, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.